{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Tempest Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"TPST"},"Address":{"label":"Address","value":"7000 SHORELINE COURT,SUITE 275 SUITE 400, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 415 798-8589"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity."},"CompanyUrl":{"label":"Company Url","value":"https://www.tempesttx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Sam Whiting","title":"Chief Medical Officer, Head-R&D"},{"name":"Stephen R. Brady","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}